Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Gynecology

Free Subscription 20.10.2025 7 Acta Obstet Gynecol Scand 2 Am J Obstet Gynecol 6 BMC Cancer 1 Br J Cancer 2 Br J Radiol 1 Cancer Res 1 Eur J Cancer 11 Eur J Obstet Gynecol Reprod Biol 6 Fertil Steril 3 Gynecol Oncol 1 Hum Pathol 1 Hum Reprod 3 Int J Cancer 9 Int J Gynaecol Obstet 1 Int J Radiat Oncol Biol Phys 1 Lancet 10 Obstet Gynecol 1 Oncogene 4 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Obstet Gynecol Scand

1. RASMUSSEN TD, Urhoj SK, Magnus MC, Soderling J, et al
   Postpartum hemorrhage after SARS-CoV-2 infection in pregnancy: A Scandinavian register-based cohort study.
   Acta Obstet Gynecol Scand. 2025 Oct 10. doi: 10.1111/aogs.70069.
   PubMed         Abstract available
   
   
2. FUNG JCY, Chaemsaithong P, Chen Y, Yuenyongdechawat N, et al
   Predicting spontaneous preterm birth with cervical length and fetal fibronectin for symptomatic women of threatened preterm labor: A prospective study.
   Acta Obstet Gynecol Scand. 2025 Oct 12. doi: 10.1111/aogs.70062.
   PubMed         Abstract available
   
   
3. KINNUNEN J, Nikkinen H, Keikkala E, Mustaniemi S, et al
   Gestational diabetes mellitus and offspring health: A 12-year register-based analysis of specialized health care utilization in Finland.
   Acta Obstet Gynecol Scand. 2025 Oct 12. doi: 10.1111/aogs.70077.
   PubMed         Abstract available
   
   
4. LIA M, Dathan-Stumpf A, Franke J, Vogt B, et al
   Prediction of obstetric outcome in vaginal breech birth using ultrasound pelvimetry in nulliparous women-A feasibility study.
   Acta Obstet Gynecol Scand. 2025 Oct 12. doi: 10.1111/aogs.70072.
   PubMed         Abstract available
   
   
5. FOX A, Doyle E, Reynolds A, Farren M, et al
   Placental pathology and its association with duration of abnormal fetal heart tracing in near-term and term infants with hypoxic-ischemic encephalopathy: A retrospective study.
   Acta Obstet Gynecol Scand. 2025 Oct 15. doi: 10.1111/aogs.70064.
   PubMed         Abstract available
   
   
6. GALKA K, Shea M, Aye CYL, Impey L, et al
   Carbon monoxide levels, smoking, and adverse pregnancy outcomes.
   Acta Obstet Gynecol Scand. 2025 Oct 15. doi: 10.1111/aogs.70068.
   PubMed         Abstract available
   
   
7. PHALOPRAKARN C, Jenkumwong P, Suthasmalee S, Chavanisakun C, et al
   Umbilical venous blood flow and its association with placental pathology in pregnancies complicated by gestational diabetes mellitus.
   Acta Obstet Gynecol Scand. 2025 Oct 15. doi: 10.1111/aogs.70073.
   PubMed         Abstract available
   
   

   
   Am J Obstet Gynecol

8. MORTIMER R, Srouji S, Doubilet P, Ginsburg E, et al
   Ultrasound diagnosis of early pregnancy loss in an in-vitro fertilization population.
   Am J Obstet Gynecol. 2025 Oct 9:S0002-9378(25)00728.
   PubMed         Abstract available
   
   
9. NOLIN AC, Atkins S, Brucker A, Sun L, et al
   Performance of ultrasound and rates of guideline-concordant care in a diverse postmenopausal bleeding cohort.
   Am J Obstet Gynecol. 2025 Oct 10:S0002-9378(25)00730.
   PubMed         Abstract available
   
   

   
   BMC Cancer

10. LI R, Zhang X, Shen J
    Combination of immunotherapy and chemotherapy as first-line treatment for advanced or recurrent endometrial cancer: a meta-analysis of phase 3 trials.
    BMC Cancer. 2025;25:1579.
    PubMed         Abstract available
    
    
11. OZGEN L, Yalcin Y, Abay M, Ozerkan K, et al
    Impact of uterine adenomyosis on survival outcome of patients with non-endometrioid endometrial cancer.
    BMC Cancer. 2025;25:1574.
    PubMed         Abstract available
    
    
12. SETSOAFIA EA, Sarfo-Annan G, Daniels J, Addae J, et al
    Experiences of patients with cervical cancer undergoing concurrent chemoradiation therapy at the Korle-Bu teaching hospital in Ghana: an explorative qualitative study.
    BMC Cancer. 2025;25:1547.
    PubMed         Abstract available
    
    
13. TESFOM HN, Gizaw M, Yilam M, Klein JMA, et al
    Prevalence and factors associated with high-risk human papillomavirus infection and cervical lesions among women with HIV in Addis Ababa, Ethiopia.
    BMC Cancer. 2025;25:1557.
    PubMed         Abstract available
    
    
14. JIANG P, Wei S, Li C, Qu A, et al
    Safety and efficacy of toripalimab plus concurrent chemoradiotherapy for locally advanced cervical cancer: a single-arm, phase Ib trial.
    BMC Cancer. 2025;25:1566.
    PubMed         Abstract available
    
    
15. JIAO H, Tian J, Liu Q, Jiang M, et al
    Analysis of FNDC1 as a diagnostic marker and potential therapeutic target for ovarian serous cancer.
    BMC Cancer. 2025;25:1595.
    PubMed         Abstract available
    
    

    
    Br J Cancer

16. WANG W, Gao M, Gao Y, Zheng H, et al
    Integrating homologous recombination deficiency subtyping with TCGA molecular classification for enhanced prognostic stratification and personalised therapy in endometrial cancer.
    Br J Cancer. 2025 Oct 14. doi: 10.1038/s41416-025-03179.
    PubMed         Abstract available
    
    

    
    Br J Radiol

17. TANAKA YO, Tanaka K, Tonooka A, Ito A, et al
    Imaging features of mesonephric-like adenocarcinoma of the endometrium.
    Br J Radiol. 2025 Oct 15:tqaf257. doi: 10.1093.
    PubMed         Abstract available
    
    
18. ISHIGURO T, Saida T, Minami M, Mori K, et al
    MRI localization evaluation to distinguish gastric-type adenocarcinoma and lobular endocervical glandular hyperplasia from other cystic lesions.
    Br J Radiol. 2025 Aug 4:tqaf191. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Cancer Res

19. CARDENAS H, Wang Y, Zhao G, Hao DX, et al
    Metabolic Dependency on De Novo Pyrimidine Synthesis is a Targetable Vulnerability in Platinum Resistant Ovarian Cancer.
    Cancer Res. 2025 Oct 15. doi: 10.1158/0008-5472.CAN-25-0043.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

20. RAMESH-KUMAR D, Sanchez-Castillo A, Soler M, Martin-Tejera JF, et al
    Specific targeting of the pseudogene RPSAP52 reduces ovarian tumor growth in patient-derived orthoxenograft models.
    Eur J Cancer. 2025;230:116040.
    PubMed         Abstract available
    
    

    
    Eur J Obstet Gynecol Reprod Biol

21. TAIRY D, Weiner E, Engel A, Paz A, et al
    The 5-year results of an institutional shadowing program aiming to train new senior "obstetricians on-call".
    Eur J Obstet Gynecol Reprod Biol. 2025;315:114760.
    PubMed         Abstract available
    
    
22. SIEGLER Y, Omer A, Yousef Y, Ben David C, et al
    Timing matters: Surgery-to-chemotherapy interval and outcomes in ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2025;315:114772.
    PubMed         Abstract available
    
    
23. POURALI L, Mottaghi M, Baghal Safa Z, Mehrad-Majd H, et al
    Lower urinary tract symptoms in late pregnancy: A cross-sectional study and narrative review.
    Eur J Obstet Gynecol Reprod Biol. 2025;315:114743.
    PubMed         Abstract available
    
    
24. TANAKA YO, Ota Y, Tamura A, Kobori H, et al
    MRI as a promising tool for adhesion assessment in endometriosis: a feasibility study with laparoscopic correlation.
    Eur J Obstet Gynecol Reprod Biol. 2025;315:114756.
    PubMed         Abstract available
    
    
25. LINARES S, Reyes O
    Perinatal outcomes in patients with preeclampsia and elevated sFlt-1/PlGF before term. A retrospective cohort study.
    Eur J Obstet Gynecol Reprod Biol. 2025;315:114770.
    PubMed         Abstract available
    
    
26. KARA L, Cicek D, Sarikaya E, Gok E, et al
    Adolescent PCOS and metabolic health: An analysis of fat, muscle, and hormones.
    Eur J Obstet Gynecol Reprod Biol. 2025;314:114648.
    PubMed         Abstract available
    
    
27. SAWANT S, Tulsyan S, Homburg R
    The influence of serum luteinising hormone concentrations post GnRH agonist trigger on metaphase II oocytes in IVF/ICSI cycles.
    Eur J Obstet Gynecol Reprod Biol. 2025;314:114663.
    PubMed         Abstract available
    
    
28. ZHAO Q, Lv S, Liu F
    Combined therapy for LSIL with HR-HPV: CO(2) laser and interferon alpha2a.
    Eur J Obstet Gynecol Reprod Biol. 2025;314:114686.
    PubMed         Abstract available
    
    
29. MCKEOWN C, Kumar P, Cheung M, Marchocki Z, et al
    Beyond the transformation zone: Outcomes in the management of CGIN over five years.
    Eur J Obstet Gynecol Reprod Biol. 2025;314:114712.
    PubMed         Abstract available
    
    
30. BRUN JL, Bergeron C, Averous G, Ardaens K, et al
    Management of women with abnormal cervical cytology: Update of French guidelines after the implementation of HPV screening.
    Eur J Obstet Gynecol Reprod Biol. 2025;314:114661.
    PubMed         Abstract available
    
    
31. LEE E, Mian S, Bormes K, Chaves K, et al
    Safety and feasibility of same-day myomectomy discharge in a community healthcare system.
    Eur J Obstet Gynecol Reprod Biol. 2025;314:114694.
    PubMed         Abstract available
    
    

    
    Fertil Steril

32. HUANG C, Li N, Li J, Huang D, et al
    Pregnancy resulting from IVF/ICSI does not affect the ability of IgG transplacental transfer.
    Fertil Steril. 2025 Oct 9:S0015-0282(25)01950.
    PubMed        
    
    
33. LUNA C, Blain Y, Aristizabal J, Amirian H, et al
    Interobserver Agreement of the FIGO Classification for uterine fibroids.
    Fertil Steril. 2025 Oct 9:S0015-0282(25)01949.
    PubMed        
    
    
34. MAGNUS MC, Alavi DT, Nydal S, Fraser A, et al
    Risk of endometriosis, adenomyosis and related symptoms among female offspring according to conception by assisted reproductive technologies.
    Fertil Steril. 2025 Oct 9:S0015-0282(25)01952.
    PubMed         Abstract available
    
    
35. LEE DY, Kim SE, Choi D
    Effect of tamoxifen on the size of existing leiomyomas in postmenopausal women with breast cancer.
    Fertil Steril. 2025 Oct 10:S0015-0282(25)01981.
    PubMed        
    
    
36. TAHERMANESH K, Allahqoli L, Bozorgmehr B, Babaheidarian P, et al
    Comprehensive evaluation of residual myometrial thickness of cesarean scar in uterine samples after hysterectomy.
    Fertil Steril. 2025 Oct 13:S0015-0282(25)01984.
    PubMed        
    
    
37. CONVERSA L, Gimenez-Rodriguez C, Murria L, Alegre L, et al
    Post-warming re-expansion and contraction dynamics of vitrified blastocysts: shrinkage magnitude and timing correlate with pregnancy outcome.
    Fertil Steril. 2025 Oct 14:S0015-0282(25)01991.
    PubMed         Abstract available
    
    

    
    Gynecol Oncol

38. POWELL CA, Winer IS, Tarney CM, Gaillard S, et al
    Interstitial lung disease in targeted therapies: A Society of Gynecologic Oncology clinical practice statement.
    Gynecol Oncol. 2025;202:137-145.
    PubMed         Abstract available
    
    
39. ETTORRE VM, Bellone S, Buza N, Hui P, et al
    Immunohistochemistry, next generation sequencing (NGS), and whole exome sequencing concordance in HER2 testing in uterine serous carcinoma: a retrospective analysis.
    Gynecol Oncol. 2025;202:131-136.
    PubMed         Abstract available
    
    
40. BORDEN BA, Rodriguez-Hernandez A, Trottier M, Horiguchi M, et al
    SMARCA4 pathogenic variants: Gynecological cancer histories from a laboratory tested cohort.
    Gynecol Oncol. 2025;202:125-130.
    PubMed         Abstract available
    
    

    
    Hum Pathol

41. SCHOOLMEESTER JK, Hodge JC, Swanson AA
    HMGA2 and RB1 profiling in uterine and broad ligament leiomyomas with adipocytic differentiation: An immunohistochemical and fluorescence in situ hybridization study of 14 conventional and variant lipoleiomyomas.
    Hum Pathol. 2025 Oct 12:105950. doi: 10.1016/j.humpath.2025.105950.
    PubMed        
    
    

    
    Hum Reprod

42. LEROY R, Abbott J, Benahmed N, Camberlin C, et al
    Comparative analysis of the organization of endometriosis care in five high-income countries: implications for health systems and policy.
    Hum Reprod. 2025 Oct 14:deaf190. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Int J Cancer

43. CHINULA L, Chagomerana MB, Mkochi T, Msowoya L, et al
    Single visit screen-triage-treat strategy using GeneXpert-based HPV testing of self-collected cervicovaginal samples and thermal ablation treatment for cervical cancer prevention among women in Lilongwe, Malawi.
    Int J Cancer. 2025 Oct 16. doi: 10.1002/ijc.70177.
    PubMed         Abstract available
    
    
44. HERNANDEZ-BERNAL F, Bernal KS, Bequet-Romero M, Martin-Bauta Y, et al
    HEBERSaVax immunotherapy combined with first-line chemotherapy in advanced ovarian cancer: Phase II CENTAURO-4 trial results.
    Int J Cancer. 2025 Oct 16. doi: 10.1002/ijc.70199.
    PubMed         Abstract available
    
    
45. YU X, Nzoutchoum OL, Gao D, Hsu CD, et al
    Cervical cancer screening and prevalence among older US Medicare beneficiaries with and without HIV.
    Int J Cancer. 2025 Oct 13. doi: 10.1002/ijc.70193.
    PubMed         Abstract available
    
    

    
    Int J Gynaecol Obstet

46. OZER E, Akman AO, Kurtipek FB, Buyukyilmaz G, et al
    Anovulatory bleeding and the spectrum of bleeding disorders: Understanding heavy menstrual bleeding in adolescents.
    Int J Gynaecol Obstet. 2025 Oct 10. doi: 10.1002/ijgo.70579.
    PubMed         Abstract available
    
    
47. URBANO FP, Cury GR, Dos Santos CR, da Silva DJC, et al
    Introduction of DNA-HPV test in the Brazilian cervical cancer screening program: When the idea is good but does not fit the budget.
    Int J Gynaecol Obstet. 2025 Oct 14. doi: 10.1002/ijgo.70594.
    PubMed         Abstract available
    
    
48. GUAN X, Yang Q, Zhang V, Zhang C, et al
    Robotic-assisted transumbilical single-site and transvaginal NOTES resection of abdominal wall cesarean scar endometriosis: Two case reports.
    Int J Gynaecol Obstet. 2025 Oct 14. doi: 10.1002/ijgo.70582.
    PubMed        
    
    
49. DHABEKAR PD, Srivastava N, Deshmukh K, Saravanan K, et al
    Association between the female survivors of childhood, adolescent, and young adult cancer and the adverse obstetric and feto-maternal outcomes: A systematic review and meta-analysis.
    Int J Gynaecol Obstet. 2025 Oct 14. doi: 10.1002/ijgo.70583.
    PubMed         Abstract available
    
    
50. DHIMAN S, Sharma KA, Dadhwal V, Gupta A, et al
    Predictive factors for adverse pregnancy outcomes in women with rheumatic valvular heart disease: A single-center retrospective analysis.
    Int J Gynaecol Obstet. 2025 Oct 16. doi: 10.1002/ijgo.70595.
    PubMed         Abstract available
    
    
51. BRENTA A, Cesari E, Bonato S, Savasi VM, et al
    Spontaneous uterine rupture after myomectomy in patients during pregnancy: Clinical cases in a single university center.
    Int J Gynaecol Obstet. 2025 Oct 16. doi: 10.1002/ijgo.70592.
    PubMed         Abstract available
    
    
52. IRWIN K, Dennis A, Howard H, Jones G, et al
    Enhancing diversity in endometriosis clinical trials: Application of the clinical diversity scoring framework.
    Int J Gynaecol Obstet. 2025 Oct 16. doi: 10.1002/ijgo.70590.
    PubMed        
    
    
53. ALDIKA AKBAR MI, Gumilar KE, Pribadi A, Aziz MA, et al
    The Indonesia pre-eclampsia study (INAPRES): Pregnancy outcomes in pregnancy with pre-eclampsia in Indonesia.
    Int J Gynaecol Obstet. 2025 Oct 16. doi: 10.1002/ijgo.70587.
    PubMed         Abstract available
    
    
54. ALSHAMLAN NA, AlOmar RS, Al Qahtani NH, Badghaish FS, et al
    Bridging women's emergency and primary healthcare: Factors associated with prolonged obstetrics and gynecology emergency room stay in a Saudi university hospital.
    Int J Gynaecol Obstet. 2025 Oct 17. doi: 10.1002/ijgo.70603.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

55. HATHOUT L, Leung E, Taunk NK, Ludwig M, et al
    From Supportive Care to Treatment De-Escalation: Sexual Health and Quality of Life Outcomes in Recent Gynecologic Cancer Trials.
    Int J Radiat Oncol Biol Phys. 2025;123:913-916.
    PubMed        
    
    

    
    Lancet

56. BEKKER LG, Joseph Davey D, Saidi F
    Two for two: lenacapavir during pregnancy and lactation.
    Lancet. 2025;406:1560-1561.
    PubMed        
    
    

    
    Obstet Gynecol

57. GREENBERG M, Zhu Y, Shan J, Hedderson MM, et al
    Gestational and Pregestational Diabetes Screening Changes in Early Pregnancy and Perinatal Outcomes.
    Obstet Gynecol. 2025 Oct 16. doi: 10.1097/AOG.0000000000006090.
    PubMed         Abstract available
    
    
58. BHADRA-HEINTZ N, Schapiro R, Roder N, Casey E, et al
    Extended-Release Buprenorphine for Treatment of Opioid Use Disorder During Pregnancy and Postpartum.
    Obstet Gynecol. 2025 Oct 16. doi: 10.1097/AOG.0000000000006091.
    PubMed         Abstract available
    
    
59. IGLESIA CB, Kim KH, King CR
    What's Hot in Gynecologic Surgery Circa 2025.
    Obstet Gynecol. 2025;146:613-614.
    PubMed        
    
    
60. NELSON HN, Estrada F, Dragoman MV, Atrio J, et al
    Advances in Imaging for Placenta Accreta Spectrum Disorder.
    Obstet Gynecol. 2025;146:e85.
    PubMed        
    
    
61. WALLER JA, Shamshirsaz A, Abuhamad A
    Advances in Imaging for Placenta Accreta Spectrum Disorder.
    Obstet Gynecol. 2025;146:e85-e86.
    PubMed        
    
    
62. HUANG KJ
    Cardiovascular Disease After Hysterectomy in the Nurses' Health Study and Nurses' Health Study II.
    Obstet Gynecol. 2025;146:e86.
    PubMed        
    
    
63. RASSIER SLC, Thao V, Borah B, Farland LV, et al
    Cardiovascular Disease After Hysterectomy in the Nurses' Health Study and Nurses' Health Study II.
    Obstet Gynecol. 2025;146:e86-e87.
    PubMed        
    
    
64. 
    ACOG Committee Statement No. 21: Access to Contraception.
    Obstet Gynecol. 2025;146:e88-e97.
    PubMed         Abstract available
    
    
65. FALLAH PN, Bowman P, Tran C, Chen V, et al
    Implementation of Human Papillomavirus Self-Collection and Barriers to Follow-Up Among Unhoused Individuals in Texas: The EMPOWER Study.
    Obstet Gynecol. 2025;146:710-717.
    PubMed         Abstract available
    
    
66. 
    ACOG Committee Statement No. 22: Anticipatory Counseling Regarding Ovarian-Factor Fertility Decline.
    Obstet Gynecol. 2025;146:e98-e104.
    PubMed         Abstract available
    
    

    
    Oncogene

67. WU L, Wu C, He S, Chen Y, et al
    METAP2 inhibits K48-linked ubiquitination of YTHDF2 to promote ovarian cancer progression.
    Oncogene. 2025 Oct 16. doi: 10.1038/s41388-025-03594.
    PubMed         Abstract available
    
    

    
    PLoS One

68. ZHAO X, Kong W, Jiang Y, Sui F, et al
    Current and future burden of gynecological cancers attributable to high body-mass index: A comprehensive global analysis and projection study.
    PLoS One. 2025;20:e0333281.
    PubMed         Abstract available
    
    
69. ZHANG Z, Li Y, Huang H, Wei T, et al
    Disparities and trends of the incidence and mortality of female-specific cancers in the United States.
    PLoS One. 2025;20:e0334128.
    PubMed         Abstract available
    
    
70. CHOU HH, Chu PY, Wu YH, Feng C, et al
    Health impact and cost-effectiveness analysis of gender-neutral versus female-only 9-valent human papillomavirus vaccination in Taiwan.
    PLoS One. 2025;20:e0333757.
    PubMed         Abstract available
    
    
71. LARSSON GL, Carlsson J, Helenius G, Bergengren L, et al
    Molecular triage on HPV-positive samples in a cervical screening setting.
    PLoS One. 2025;20:e0333539.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gynecology is free of charge.